Publication

ADPKD: Risk Prediction for Treatment Selection

Messchendorp, A. L., 2019, [Groningen]: Rijksuniversiteit Groningen. 292 p.

Research output: ThesisThesis fully internal (DIV)Academic

Copy link to clipboard

Documents

  • Title and contents

    Final publisher's version, 352 KB, PDF-document

  • Chapter 1

    Final publisher's version, 1 MB, PDF-document

  • Chapter 2

    Final publisher's version, 1 MB, PDF-document

  • Chapter 3

    Final publisher's version, 1 MB, PDF-document

  • Chapter 4

    Final publisher's version, 1 MB, PDF-document

  • Chapter 5

    Final publisher's version, 2 MB, PDF-document

    Embargo ends: 25/02/2020

    Request copy

  • Chapter 6

    Final publisher's version, 2 MB, PDF-document

  • Chapter 7

    Final publisher's version, 865 KB, PDF-document

  • Chapter 8

    Final publisher's version, 939 KB, PDF-document

    Embargo ends: 25/02/2020

    Request copy

  • Chapter 9

    Final publisher's version, 672 KB, PDF-document

    Embargo ends: 25/02/2020

    Request copy

  • Chapter 10

    Final publisher's version, 3 MB, PDF-document

  • Chapter 11

    Final publisher's version, 370 KB, PDF-document

  • Nederlandse samenvatting

    Final publisher's version, 264 KB, PDF-document

  • Dankwoord

    Final publisher's version, 245 KB, PDF-document

  • List of publications

    Final publisher's version, 164 KB, PDF-document

  • Complete thesis

    Final publisher's version, 14 MB, PDF-document

    Embargo ends: 25/02/2020

    Request copy

  • Propositions

    Final publisher's version, 77 KB, PDF-document

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inheritable kidney disease. It is characterized by progressive kidney cyst
formation throughout life, which can lead to kidney failure. However, only 70% of patients will develop kidney failure and the age at which patients develop
kidney failure shows a large interindividual variability. It is therefore difficult to predict the rate of disease progression in an individual patient. Obviously,
the ability to predict the rate of disease progression in patients with ADPKD would help patients and caregivers alike in treatment related decisions.
Patients with a higher rate of disease progression will probably benefit the most from therapy, since in these patients the benefit to risk ratio of treatment
is expected to be better, especially when treatment is started early. Currently, there are several variables used to predict the rate of disease progression
in ADPKD like kidney volume and the DNA mutation which underlies the disease. However, these variables are expensive and laborious to assess,
less sensitive at an individual patient level and not always available in routine clinical care. The aim of this thesis was therefore to study if current used
variables could be improved and to search for new variables that predict disease progression in ADPKD. The studies described in this thesis bring us
closer to the answer to the question how we can identify patients in a clinically applicable way with rapidly progressive ADPKD, who are eligible for
treatment.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Supervisors/Advisors
Award date25-Feb-2019
Place of Publication[Groningen]
Publisher
Print ISBNs978-94-6375-264-0
Electronic ISBNs978-94-6375-283-1
Publication statusPublished - 2019

View graph of relations

Download statistics

No data available

ID: 75440764